1. Home
  2. LAES vs TECX Comparison

LAES vs TECX Comparison

Compare LAES & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$2.83

Market Cap

675.0M

Sector

Technology

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$34.54

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
TECX
Founded
2022
2019
Country
Switzerland
United States
Employees
N/A
60
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
675.0M
549.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
LAES
TECX
Price
$2.83
$34.54
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$4.00
$75.20
AVG Volume (30 Days)
18.2M
182.5K
Earning Date
03-31-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$93.36
N/A
Revenue Next Year
$43.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$14.39
52 Week High
$8.71
$39.53

Technical Indicators

Market Signals
Indicator
LAES
TECX
Relative Strength Index (RSI) 40.14 57.62
Support Level $2.59 $27.31
Resistance Level $3.40 $35.99
Average True Range (ATR) 0.23 2.47
MACD -0.04 0.25
Stochastic Oscillator 11.81 50.14

Price Performance

Historical Comparison
LAES
TECX

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: